---
title: "蘇州近岸蛋白質科技股份有限公司 (688137.SH)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/688137.SH.md"
symbol: "688137.SH"
name: "蘇州近岸蛋白質科技股份有限公司"
industry: "生物技術"
---

# 蘇州近岸蛋白質科技股份有限公司 (688137.SH)

| Item | Detail |
|------|--------|
| Industry | 生物技術 |
| Location | 滬深市場 |
| Website | [www.novoprotein.com.cn](https://www.novoprotein.com.cn) |

## Company Profile

公司深耕重組蛋白行業多年，是一家專注于蛋白質技術與應用解決方案的高新技術企業，公司在上海、蘇州和菏澤建有研發、生產基地。公司以完善的技術體系和自產創新原料為基礎，為生物醫藥行業提供從產品到技術創新及開發的一站式服務。公司主營業務為靶點及因子類蛋白、重組抗體、酶及試劑的研發、生產和銷售及提供生物藥、體外診斷、生命科學基礎研究等領域的全流程應用解決方案。公司主要產品為靶點及因子類蛋白、重組抗體、酶及試劑、CRO 服務。企業榮譽:“亞太區 CGT 行業之星——2023 年度最優原材料提供商”、“2023 未來醫療 100 強·創新醫療商業及供應鏈服務榜 TOP100”、“2023 年合成生物學產業價...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-18T04:30:10.000Z

**Overall: C (0.52)**

**Industry**: Biotechnology

| Metric | Value |
|--------|-------|
| Industry Ranking | 56 / 81 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 9.49% |  |
| Net Profit YoY | -205.36% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 1.48 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 3.07B |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 147.33M |  |


**Multi Score**: C

#### Profit Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -3.08% | D |
| Profit Margin | -44.13% | E |
| Gross Margin | 111.10% | A |

#### Growth Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 9.49% | B |
| Net Profit YoY | -205.36% | E |
| Total Assets YoY | -2.16% | D |
| Net Assets YoY | -2.55% | D |

#### Cash Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | -226.60% | D |
| OCF YoY | 9.49% | B |

#### Operating Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.07 | E |

#### Debt Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 5.23% | A |


```chart-data:radar
{
  "title": "Longbridge Financial Score - 蘇州近岸蛋白質科技股份有限公司",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "-3.08%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "-44.13%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "111.10%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "C",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "9.49%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "-205.36%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "-2.16%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "-2.55%",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "C",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "-226.60%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "9.49%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "E",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.07",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "A",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "5.23%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | 百濟神州-U (SH.688235) | C | A | B | C | A | B |
| 02 | 甘李藥業 (SH.603087) | B | B | D | A | B | B |
| 03 | 三生國健 (SH.688336) | A | B | D | B | C | B |
| 04 | 百奧賽圖 (SH.688796) | A | A | C | D | B | B |
| 05 | 天壇生物 (SH.600161) | B | B | C | A | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -47.23 | 63/83 | - | - | - |
| PB | 1.48 | 12/83 | 1.49 | 1.38 | 1.15 |
| PS (TTM) | 20.84 | 66/83 | 21.70 | 20.25 | 18.19 |
| Dividend Yield | 0.00% | - | 1.50% | 1.42% | 1.28% |

## References

- [Company Overview](https://longbridge.com/en/quote/688137.SH/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/688137.SH/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/688137.SH/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.